Literature DB >> 7863261

Monosialoganglioside GM3 induces CD4 internalization in human peripheral blood T lymphocytes.

M Sorice1, A Pavan, R Misasi, T Sansolini, T Garofalo, L Lenti, G M Pontieri, L Frati, M R Torrisi.   

Abstract

Gangliosides modulate the expression of CD4 molecules on the cell surface of T lymphocytes. We report here that treatment of human peripheral blood lymphocytes with exogenous monosialoganglioside GM3 induces a rapid down-modulation of the CD4 molecules on the plasma membrane of CD4+ T lymphocytes, as assessed by cytofluorimetric analysis and quantitative immunoelectron microscopy. The CD4 down-modulation was ganglioside-dose dependent and was already evident after 5 min of treatment, reaching the maximum after 20 min. The expression of other surface antigens was not affected by GM3 treatment. The immunoelectron microscopic analysis showed that, following GM3 addition, gold labelled CD4 molecules were rapidly redistributed on the cell surface, clustered and internalized via endocytic pits and vesicles. These results indicate that CD4 down-modulation induced by GM3 occurs through an endocytic mechanism. A persistent low level of CD4 expression on the cell surface up to 24 h after GM3 treatment, compared with a stable expression of either CD4 in untreated cells and CD3 in GM3-treated cells, suggests intracellular degradation of the internalized CD4 molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7863261     DOI: 10.1111/j.1365-3083.1995.tb03547.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Association between GM3 and CD4-Ick complex in human peripheral blood lymphocytes.

Authors:  M Sorice; T Garofalo; R Misasi; A Longo; J Mikulak; V Dolo; G M Pontieri; A Pavan
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

2.  Ganglioside expression in tissues of mice lacking beta2-microglobulin.

Authors:  A Markotić; A Marusić; J Tomac; J Müthing
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.

Authors:  Ana Victoria Casadesús; Yuniel Fernández-Marrero; Marilyn Clavell; José Alberto Gómez; Tays Hernández; Ernesto Moreno; Alejandro López-Requena
Journal:  Glycoconj J       Date:  2013-04-02       Impact factor: 2.916

4.  Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.

Authors:  Satinder S Rawat; Stephen A Gallo; Julie Eaton; Thomas D Martin; Sherimay Ablan; Vineet N KewalRamani; Ji Ming Wang; Robert Blumenthal; Anu Puri
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.

Authors:  Tania Lahera; Adanays Calvo; Griselda Torres; Charles E Rengifo; Santiago Quintero; María Del Carmen Arango; Debora Danta; José M Vázquez; Xiomara Escobar; Adriana Carr
Journal:  J Oncol       Date:  2014-01-30       Impact factor: 4.375

6.  Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.

Authors:  Ana M H Vázquez; Nely Rodrèguez-Zhurbenko; Ana M V López
Journal:  Front Oncol       Date:  2012-11-20       Impact factor: 6.244

Review 7.  Role of GM3-enriched microdomains in signal transduction regulation in T lymphocytes.

Authors:  Maurizio Sorice; Agostina Longo; Tina Garofalo; Vincenzo Mattei; Roberta Misasi; Antonio Pavan
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.